TY - JOUR
KW - Drug Abuse And Alcoholism
KW - opioid use disorder
KW - buprenorphine
KW - Medications for opioid use disorder
KW - Distress tolerance
KW - Motivational enhancement
KW - Mobile treatment
KW - Adherence
KW - Drug Withdrawal
KW - Usability
KW - Retention
KW - Outpatient Treatment
KW - Intervention
KW - Stabilization
KW - Opioids
KW - Side effects
KW - Emotional distress
KW - Efficacy
KW - Negative affectivity
KW - Tolerance
KW - naloxone
KW - Physical symptoms
KW - narcotics
KW - Substance abuse disorders
KW - clinical outcomes
KW - feasibility
KW - Negative affect
KW - Drugs
KW - Motivation
KW - Drug Use
KW - Clinical Trials
KW - Individualized
KW - Brief interventions
KW - Analgesics
KW - medical treatment
KW - Psychological Distress
KW - Patient Compliance
KW - Health Behavior
KW - Substance abuse treatment
AU - Kirsten J. Langdon
AU - Susan Ramsey
AU - Caroline Scherzer
AU - Kate Carey
AU - Megan L. Ranney
AU - Josiah Rich
A1 - 
BT - Addiction Science & Clinical Practice
C5 - Education & Workforce; HIT & Telehealth; Opioids & Substance Use
CY - London
DO - 10.1186/s13722-020-00189-4
JF - Addiction Science & Clinical Practice
LA - English
M1 - Journal Article
PB - BioMed Central
PP - London
PY - 2020
SN - 19400632
SP - 1
EP - 10
EP - 
T1 - Development of an integrated digital health intervention to promote engagement in and adherence to medication for opioid use disorder
T2 - Addiction Science & Clinical Practice
TI - Development of an integrated digital health intervention to promote engagement in and adherence to medication for opioid use disorder
U1 - Education & Workforce; HIT & Telehealth; Opioids & Substance Use
U3 - 10.1186/s13722-020-00189-4
UR - https://www.proquest.com/scholarly-journals/development-integrated-digital-health/docview/2404286508/se-2?accountid=28100
VL - 15
VO - 19400632
Y1 - 2020
ER -